MTOR and gastric cancer: To verify this hypothesis, we analyzed the effect of PI3K/mTOR inhibition on signaling pathways in the PTEN-deficient gastric cancer HGC-27 cells using a phosphokinase array, which included antibodies against 43 phosphoproteins (Supplementary Table 1).